Skip to main content
Log in

Exhaled nitric oxide levels in infants with chronic lung disease

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Chronic lung disease (CLD) is an inflammatory disorder; in patients with other inflammatory disorders exhaled nitric oxide (NO) levels are elevated. The aim of this study was to test the hypothesis that prematurely born infants with CLD would have elevated exhaled NO levels compared to those without CLD and healthy term-born infants. Ten infants with CLD (median gestational age 26 weeks; CLD group), ten infants without CLD (median gestational age 32 weeks; non-CLD group) and ten term-born infants (term group) were examined at post-conceptional ages between 36 and 45 weeks. NO levels were measured during spontaneous tidal breathing. A facemask was positioned over the infant’s nose and mouth and a sampling catheter was inserted through a small leak-free valve into the facemask. To measure nasal NO, the tip of the sampling catheter was placed in the nasal space and to measure facemask NO, the catheter tip was positioned inside the facemask at the infant’s lips. Nasal compared to facemask NO levels were higher in all three groups (CLD; non-CLD; term: P =0.017, P =0.012 and P =0.017, respectively). The CLD group had higher peak nasal and facemask NO levels than the non-CLD ( P =0.011 and P =0.034 respectively) and the term ( P =0.005 and P =0.01 respectively) infants. Regression analysis demonstrated that facemask NO levels were significantly related to CLD, independent of gestational, post-natal and post-conceptional age ( P =0.006). Conclusion:our results suggest that exhaled nitric oxide levels are elevated in chronic lung disease infants. Facemask measurement of nitric oxide levels might be a potentially useful method to monitor infants with chronic lung disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CLD :

chronic lung disease

NO :

nitric oxide

References

  1. Alving K, Weitzberg E, Lundberg JM (1993) Increased amount of nitric oxide in the exhaled air of asthmatics. Eur Respir J 6: 1368–1370

    Google Scholar 

  2. Archer S (1993) Measurement of nitric oxide in biological models. FASEB J 7: 349–360

    CAS  PubMed  Google Scholar 

  3. Baraldi E, Azzolin NM, Zanconato S, Dario C, Zacchello F (1997) Corticosteroids decrease exhaled nitric oxide levels in children with acute asthma. J Pediatr 131: 381–385

    CAS  PubMed  Google Scholar 

  4. Biban P, Zangardi T, Baraldi E, Dussini N, Chiandetti L, Zacchello F (2001) Mixed exhaled nitric oxide and plasma nitrites and nitrates in newborn infants. Life Sci 68: 2789–2797

    Article  CAS  PubMed  Google Scholar 

  5. Hall GL, Reinmann B, Wildhaber JH, Frey U (2002) Tidal exhaled nitric oxide in healthy, unsedated newborn infants with prenatal tobacco exposure. J Appl Physiol 92: 59–66

    CAS  PubMed  Google Scholar 

  6. Johnson AH, Peacock JL, Greenough A, Marlow N, Limb ES, Marston L, Calvert SA for the United Kingdom Oscillation Study Group (2002) High frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity. N Engl J Med 347: 633–642

    Google Scholar 

  7. Kharitonov SA, Wells AU, O’Connor BJ (1995) Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med 151: 1889–1893

    CAS  PubMed  Google Scholar 

  8. Mieskonen ST, Malmberg LP, Kari MA, Pelkonen AS, Turpeinen MT, Hallman NM, Sovijarvi AR (2002) Exhaled nitric oxide at school age in prematurely born infants with neonatal chronic lung disease. Pediatr Pulmonol 33: 347–355

    Article  PubMed  Google Scholar 

  9. Schedin U, Norman M, Gustafsson LE, Jonsson B, Frostell C (1997) Endogenous nitric oxide in the upper airways of premature and term infants. Acta Paediatr 86: 1229–1235

    CAS  PubMed  Google Scholar 

  10. Vyas JR, Currie AE, Shuker DEG, Field DJ, Kotecha S (1999) Concentration of nitric oxide products in bronchoalveolar fluid obtained from infants who develop chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 81: F217–F220

    CAS  PubMed  Google Scholar 

  11. Williams O, Rafferty GF, Hannam S, Milner AD, Greenough A (2003) Nasal and lower airway levels of nitric oxide in prematurely born infants. Early Hum Dev 72: 67–73

    Article  CAS  PubMed  Google Scholar 

  12. Williams O, Bhat RY, Cheeseman P, Rafferty GF, Hannam S, Greenough A (2004) Exhaled nitric oxide in chronically ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 89: F88–F89

    Article  CAS  PubMed  Google Scholar 

  13. Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ (1995) Effect of nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 152: 892–896

    CAS  PubMed  Google Scholar 

  14. Ziegler JW, Ivy DD, Kinsella JP, Abman SH (1995) The role of nitric oxide, endothelin, and prostaglandins in the transition of the pulmonary circulation. Clin Perinatol 22: 387–403

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anne Greenough.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leipälä, J.A., Williams, O., Sreekumar, S. et al. Exhaled nitric oxide levels in infants with chronic lung disease. Eur J Pediatr 163, 555–558 (2004). https://doi.org/10.1007/s00431-004-1480-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-004-1480-3

Keywords

Navigation